Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Other Gross PP&E Adjustments: 2020-2023

Historic Other Gross PP&E Adjustments for Candel Therapeutics (CADL) over the last 3 years, with Sep 2023 value amounting to $4.2 million.

  • Candel Therapeutics' Other Gross PP&E Adjustments rose 10.07% to $4.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $16.0 million, marking a year-over-year increase of 18.46%. This contributed to the annual value of $3.6 million for FY2022, which is 7.90% up from last year.
  • As of Q3 2023, Candel Therapeutics' Other Gross PP&E Adjustments stood at $4.2 million, which was down 0.56% from $4.3 million recorded in Q2 2023.
  • In the past 5 years, Candel Therapeutics' Other Gross PP&E Adjustments ranged from a high of $4.3 million in Q2 2023 and a low of $2.3 million during Q4 2020.
  • Moreover, its 3-year median value for Other Gross PP&E Adjustments was $3.8 million (2021), whereas its average is $3.8 million.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first surged by 47.98% in 2021, then declined by 9.06% in 2022.
  • Candel Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at $2.3 million in 2020, then soared by 47.98% to $3.4 million in 2021, then climbed by 7.90% to $3.6 million in 2022, then grew by 10.07% to $4.2 million in 2023.
  • Its last three reported values are $4.2 million in Q3 2023, $4.3 million for Q2 2023, and $3.9 million during Q1 2023.